Johnson & Johnson Sees $2.2M Bearish Put Sweep as Stock Slides to $221.76

By TrendSpider Editor

A dominant bearish put contract totaling $2,205,000 in premium has surfaced in Johnson & Johnson options activity, flagging potential downside conviction as JNJ trades at $221.76 on Monday, June 1, 2026. The stock is down 1.55% on the session, adding weight to the bearish signal embedded in the unus

Johnson & Johnson Sees $2.2M Bearish Put Sweep as Stock Slides to $221.76

A dominant bearish put contract totaling $2,205,000 in premium has surfaced in Johnson & Johnson options activity, flagging potential downside conviction as JNJ trades at $221.76 on Monday, June 1, 2026. The stock is down 1.55% on the session, adding weight to the bearish signal embedded in the unusual flow. With a 52-week range of $149.04 to $251.705, JNJ sits in the upper half of its annual range but is showing signs of near-term pressure.

Key Drivers of the JNJ Stock Move

The forward setup for JNJ is cautious given the imbalance between put and call premium. The single put contract accounts for the overwhelming majority of unusual activity this session, and its in-the-money status with more than two weeks until expiration suggests this is not a speculative lottery ticket but rather a targeted directional trade. The June 18 expiration window will capture any material company developments over the next several weeks, including potential pipeline updates, litigation news, or broader healthcare sector catalysts. Investors should monitor whether today's session weakness extends or reverses, as the $220 level appears to be a near-term pivot given the call positioning there as well.

JNJ Unusual Options Activity

Two contracts were flagged as unusual in today's session, with a combined total premium of $2,241,000 and a clear bearish lean based on premium distribution.

The put at $222.5 accounts for 98.4% of total unusual premium, reinforcing the bearish directional bias in today's flow. The call's 714% open interest ratio is notable relative to existing positioning at that strike, though the dollar commitment is comparatively minimal.

JNJ Seasonality

Early June has historically represented a transitional period for large-cap healthcare names as investors reassess sector allocations heading into mid-year. Options expiring in mid-June, such as the June 18 contract flagged today, tend to capture any volatility tied to Federal Reserve commentary and healthcare policy headlines that often surface around this time of year.

JNJ Relative Performance

JNJ is down 1.55% on the session at $221.76, underperforming on a day when broader market sentiment would need to be monitored in context. The stock remains well above its 52-week low of $149.04 but is trading roughly 12% below its 52-week high of $251.705, suggesting the stock has given back meaningful ground from peak levels and is navigating a softer near-term trend.